Related references
Note: Only part of the references are listed.Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis
David Charles et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2022)
Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputum
Clair Barber et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2022)
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel et al.
JOURNAL OF ASTHMA (2022)
Biologic Therapies for Severe Asthma
Guy G. Brusselle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management
Giovanna Elisiana Carpagnano et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2022)
Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients
Hirofumi Watanabe et al.
JOURNAL OF ASTHMA (2022)
Predictors of Low and High Exhaled Nitric Oxide Values in Asthma: A Real-World Study
Francesca Bertolini et al.
RESPIRATION (2022)
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Giorgio Walter Canonica et al.
Clinical and Molecular Allergy (2021)
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma
Laurits Frossing et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes
Sally E. Wenzel
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma
Meng Chen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Distribution of inflammatory phenotypes among patients with asthma in Jilin Province, China: a cross-sectional study
Bingqing Shi et al.
BMC PULMONARY MEDICINE (2021)
Severe asthma: One disease and multiple definitions
Diego Bagnasco et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2021)
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
P. Jane McDowell et al.
LANCET RESPIRATORY MEDICINE (2021)
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry
Eve Denton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot
Claudia Crimi et al.
RESPIRATORY MEDICINE (2021)
Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines
Dinah Parums
MEDICAL SCIENCE MONITOR (2021)
Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital
Hongwen Li et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2021)
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
Aikaterini Detoraki et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2021)
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
Corrado Pelaia et al.
JOURNAL OF ASTHMA AND ALLERGY (2021)
Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA)
M. B. Bilo et al.
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
Jonathan Corren et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Characterization of Severe Asthma Worldwide Data From the International Severe Asthma Registry
Eileen Wang et al.
CHEST (2020)
The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020
Hans-Uwe Simon et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S. Harvey et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Biologics for oral corticosteroid-dependent asthma
Insu Yilmaz
ALLERGY AND ASTHMA PROCEEDINGS (2020)
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
Enrico Heffler et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2020)
Real-word experience with mepolizumab: Does it deliver what it has promised?
Florence Schleich et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
Bruno Sposato et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)
Sonali Bose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma
Daniel P. Henriksen et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Diego Bagnasco et al.
RESPIRATORY MEDICINE (2020)
Mechanisms of non-type 2 asthma
Stephanie N. Hudey et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD
Vibeke Backer et al.
EUROPEAN CLINICAL RESPIRATORY JOURNAL (2020)
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
Jean-Pierre Llanos et al.
JOURNAL OF ASTHMA AND ALLERGY (2020)
Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
Michael C. Peters et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Merin E. Kuruvilla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
Davila Gonzalez I et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2019)
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation
Diego Bagnasco et al.
ALLERGY (2019)
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Ravdeep Kaur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
David B. Price et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2019)
Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma
Liam G. Heaney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
T2-high in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Stelios Pavlidis et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials
Xiao-feng Xiong et al.
RESPIRATORY RESEARCH (2019)
The Global Impact of Asthma in Adult Populations
Oladunni Enilari et al.
ANNALS OF GLOBAL HEALTH (2019)
Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma
Maria del Carmen Vennera et al.
THORAX (2018)
Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
Ting Liu et al.
FRONTIERS OF MEDICINE (2018)
The eosinophil For better or worse, in sickness and in health
Bruce S. Bochner
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life
S. Demarche et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of airway epithelial barrier dysfunction in pathogenesis of asthma
Yasuhiro Gon et al.
ALLERGOLOGY INTERNATIONAL (2018)
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
Eugene R. Bleecker et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Jie Gao et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Comorbid treatable traits in difficult asthma: Current evidence and clinical evaluation
T. R. Tay et al.
ALLERGY (2018)
Asthma: personalized and precision medicine
Giorgio W. Canonica et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2018)
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED
Chih-Hsi Scott Kuo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience
Bradley E. Chipps et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Diane Lefaudeux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy
Dennis Ledford et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study
Maria Kallieri et al.
POSTGRADUATE MEDICINE (2017)
Can the response to Omalizumab be influenced by treatment duration? A real-life study
Bruno Sposato et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Neutrophilic Inflammation in Asthma and Association with Disease Severity
Anuradha Ray et al.
TRENDS IN IMMUNOLOGY (2017)
Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers
Kjell Toren et al.
BMC PULMONARY MEDICINE (2017)
Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre
Sophie F. Demarche et al.
BMJ OPEN (2017)
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
Geoffrey L. Chupp et al.
LANCET RESPIRATORY MEDICINE (2017)
The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study
Mohit Bhutani et al.
PLOS ONE (2017)
Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma
Elizabeth A. Kelly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes
P. Ntontsi et al.
ALLERGY (2017)
Phenotype-Driven Therapeutics in Severe Asthma
Maria Theresa D. Opina et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2017)
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED
Chih-Hsi Scott Kuo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
The current and future role of biomarkers in type 2 cytokine-mediated asthma management
I. D. Pavord et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies
Mitchell Goldman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies
Kian Fan Chung
JOURNAL OF INTERNAL MEDICINE (2016)
Characterization of asthma endotypes: implications for therapy
Jeffrey R. Stokes et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
P. G. Gibson et al.
INTERNAL MEDICINE JOURNAL (2016)
A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan
Hae-Sim Park et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Lung-resident eosinophils represent a distinct regulatory eosinophil subset
Claire Mesnil et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?
Sophie Demarche et al.
BMC PULMONARY MEDICINE (2016)
Exhaled nitric oxide levels to guide treatment for adults with asthma
Helen L. Petsky et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Dominick E. Shaw et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Guus A. Westerhof et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath
Sue E. Harnan et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab
Isabelle J. Pouliquen et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis
Daniel A. Korevaar et al.
LANCET RESPIRATORY MEDICINE (2015)
External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
A. H. Wagener et al.
THORAX (2015)
Extended nitric oxide analysis may improve personalized anti-inflammatory treatment in asthmatic children with intermediate FENO50
A. Thornadtsson et al.
JOURNAL OF BREATH RESEARCH (2015)
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma
M. Kupczyk et al.
ALLERGY (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
Christopher Newby et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2014)
Neutrophilic asthma is characterised by increased rhinosinusitis with sleep disturbance and GERD
Jodie L Simpson
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2013)
Resorption: part 2. Diagnosis and management
J. Darcey et al.
BRITISH DENTAL JOURNAL (2013)
Normal Values and Thresholds for the Clinical Interpretation of Exhaled Nitric Oxide Levels in the US General Population Results from the National Health and Nutrition Examination Survey 2007-2010
Kay Choong See et al.
CHEST (2013)
Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma
Yotaro Takaku et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
What is an eosinophilic phenotype of asthma?
Parameswaran Nair
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects
Annette T. Hastie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
Yao Liu et al.
PLOS ONE (2013)
Discordance between asthma control clinical, physiological and inflammatory parameters in mild asthma
Marie-Eve Boulay et al.
RESPIRATORY MEDICINE (2013)
Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation
Florence N. Schleich et al.
BMC PULMONARY MEDICINE (2013)
A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic
Kelly Wong McGrath et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)
H. L. Petsky et al.
THORAX (2012)
Eosinophils Are Dispensable for Allergic Remodeling and Immunity in a Model of House Dust Mite-induced Airway Disease
Ramzi Fattouh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study
Mario Castro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Wendy C. Moore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes
Annette T. Hastie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Assessment and Reproducibility of Non-Eosinophilic Asthma Using Induced Sputum
Jodie L. Simpson et al.
RESPIRATION (2010)
Effects of steroid therapy on inflammatory cell subtypes in asthma
Douglas C. Cowan et al.
THORAX (2010)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Exhaled nitric oxide as a marker of asthma control in smoking patients
A. Michils et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cluster analysis and clinical asthma phenotypes
Pranab Haldar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
A. Michils et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
The use of exhaled nitric oxide to guide asthma management - A randomized controlled trial
Dominick E. Shaw et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Fraction of exhaled nitric oxide at 50 mL/s -: Reference values for adult lifelong never-smokers
Anna-Carin Olin et al.
CHEST (2007)
Immunoglobulin E: Role in asthma and allergic disease: Lessons from the clinic
Charles E. Owen
PHARMACOLOGY & THERAPEUTICS (2007)
Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms
Enrico Heffler et al.
RESPIRATORY MEDICINE (2006)
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
E. Ihre et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Determining asthma treatment by monitoring sputum cell counts:: effect on exacerbations
L Jayaram et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Clinical features and airway inflammation in mild asthma versus asymptomatic airway hyperresponsiveness
LP Boulet et al.
RESPIRATORY MEDICINE (2006)
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
JL Simpson et al.
RESPIROLOGY (2006)
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma
MA Berry et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma
AD Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
American Thoracic Society et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids
A Deykin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission
MW Pijnenburg et al.
THORAX (2005)
Determinants of asthma and its clinical course
BE Chipps
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2004)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
B Abraham et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
SA Kharitonov et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
P Godon et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
RH Green et al.
LANCET (2002)
Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness
R Louis et al.
ALLERGY (2002)
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
RH Green et al.
THORAX (2002)
Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship
SL Jones et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma
RJ Meijer et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Non-eosinophilic asthma: importance and possible mechanisms
J Douwes et al.
THORAX (2002)
Airway inflammation is present during clinical remission of atopic asthma
LM Van den Toorn et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The role of immunoglobulin E in allergy and asthma
TAE Platts-Mills
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control
SL Jones et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up
J Belda et al.
CHEST (2001)
TH2 cytokine-associated transcription factors in atopic and nonatopic asthma:: Evidence for differential signal transducer and activator of transcription 6 expression
P Christodoulopoulos et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Induced sputum cell counts in healthy adults
J Belda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Induced sputum cellularity - Reference values and distribution in normal volunteers
A Spanevello et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
